Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Law, Medicine & Ethics

• Publication date

  1996-09-01

• Fields of study

  Medicine, Philosophy

• Identifiers
  DOI 10.1111/j.1748-720X.1996.tb01859.xPMID 9069851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of placebos in psychiatry: a response to the draft document prepared by the Tri-Council Working Group. Canadian College of Neuropsychopharmacology.

  1996cited by this paper
• Placebo Orthodoxy in Clinical Research II: Ethical, Legal, and Regulatory Myths

  1996cited by this paper
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

  1996cited by this paper
• The use of placebo controls.

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• Comparing treatments

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• The Helsinki Declaration: timeless guide or irrelevant anachronism?

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• More on Chlamydia pneumonia and meningoencephalitis.

  1995cited by this paper
• The Use of Placebos in Clinical Trials for Acute Schizophrenia

  1995cited by this paper
• The use of placebo controls.

  1995cited by this paper
• The treatment of postmenopausal osteoporosis.

  1995cited by this paper
• When regulatory requirements conflict with ethical study design: the case of oral ondansetron.

  1994cited by this paper
• The continuing unethical use of placebo controls.

  1994cited by this paper
• Hormonal treatment of postmenopausal women.

  1994cited by this paper
• How to establish equivalence between treatments: a one-sided clinical trial in pediatric oncology.

  1994cited by this paper
• Dr. White and Colleagues Reply

  1993cited by this paper
• The issue of side effects and the "blind ability" of clinical drug trials.

  1993cited by this paper
• How Sound Is the Double-Blind Design for Evaluating Psychotropic Drugs?

  1993cited by this paper
• Side effects and the "blindability" of clinical drug trials.

  1992cited by this paper
• The problem of therapeutic equivalence with paired qualitative data: an example from a clinical trial using haemophiliacs with an inhibitor to factor VIII.

  1991cited by this paper
• Placebo-controlled trials and the logic of clinical purpose.

  1990cited by this paper
• Evaluation of active control trials in AIDS.

  1990cited by this paper
• How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology.

  1989cited by this paper
• Issues in planning and interpreting active control equivalence studies.

  1989cited by this paper
• Ethics and Regulation of Clinical Research

  1988cited by this paper
• The placebo control in clinical trials (a view from the FDA).

  1986cited by this paper
• Does short term placebo treatment of chronic schizophrenia produce long term harm?

  1986cited by this paper
• Double blind: double talk or are there ways to do better research.

  1986cited by this paper
• The use of placebos in randomized clinical trials.

  1985cited by this paper
• The Religion of Statistics as Practiced in Medical Journals

  1985cited by this paper
• Explication and Implications of the Placebo Concept

  1984cited by this paper
• Why do we need some large, simple randomized trials?

  1984cited by this paper
• Government Viewpoint of Clinical Trials

  1982cited by this paper
• An Investigation of Drug Expectancy as a Function of Capsule Color and Size and Preparation Form

  1982cited by this paper
• "Proving the null hypothesis" in clinical trials.

  1981cited by this paper
• Placebos in clinical trials of duodenal ulcer: the end of an era?

  1980cited by this paper
• Lying: Moral Choice in Public and Private Life

  1980cited by this paper
• Sample size requirements for evaluating a conservative therapy.

  1978cited by this paper
• The placebo dilemma

  1978cited by this paper
• Effect of capsule colour and order of administration of hypnotic treatments

  1978cited by this paper
• Interaction of drug therapy with marital therapy in depressive patients.

  1975cited by this paper
• Simple Analgesics for Arthritis

  1974cited by this paper
• Study on the Effects of Tablet Colour in the Treatment of Anxiety States

  1970cited by this paper
• Modification of placebo effects by means of drugs: effects of aspirin and placebos on self-rated moods.

  1970cited by this paper
• The Effect of Expectation on Response to Phenmetrazine

  1964cited by this paper
• The Structure of Scientific Revolutions. Chicago (University of Chicago Press) 1962.

  1962cited by this paper
• Further studies on the pharmacology of placebo administration.

  1958cited by this paper

• The Ethics of Placebo.

  2024cites this paper
• Some superiority trials with non-significant results published in high impact factor journals correspond to non-inferiority situations: a research-on-research study.

  2024cites this paper
• Ethics in placebo-controlled, acute treatment trials in schizophrenia: Two rival ethical frameworks.

  2024cites this paper
• Taking the principle of the primacy of the human being seriously

  2021cites this paper
• A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise.

  2020cites this paper
• Globalization of Clinical Research and Assessment of Global Access to Treatments Approved between 2006-2015

  2019cites this paper
• Effect of a New Synergistic Combination of Low Doses of Acetylsalicylic Acid, Caffeine, Acetaminophen, and Chlorpheniramine in Acute Low Back Pain

  2019cites this paper
• etting-up a clinical trial : Some methodological ecommendations

  2018cites this paper
• Placebo Groups in Research on the Effectiveness of ABA Therapeutic Techniques

  2018cites this paper
• Antithrombotic Therapy in Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Network Meta-Analysis

  2017cites this paper
• Therapeutic Bene a cence and Placebo Controls

  2017cites this paper
• Biopharmaceutical Innovation Responsibility and Ethical Use of Placebo

  2017cites this paper
• Setting-up a clinical trial: Some methodological recommendations

  2017cites this paper
• Chapter 6 – Trial Design, Measurement, and Analysis of Clinical Investigations

  2016cites this paper
• Journal of Neurotherapy: Investigations in Neuromodulation, Neurofeedback and Applied Neuroscience Pills, Politics, and Placebos

  2016cites this paper
• Risk based survey evidence supports electronic informed consent as a recruitment method for UK clinical trials.

  2016cites this paper
• Placebo orthodoxy and the double standard of care in multinational clinical research

  2015cites this paper
• Placebo orthodoxy and the double standard of care in multinational clinical research

  2015cites this paper
• Clinical Trials of New Drug Products: What Gets Compared to Whom

  2015cites this paper
• Ethical Overview of Placebo Control in Psychiatric Research - Concepts and Challenges.

  2015cites this paper
• Placebo-Controlled Trials, Ethics of

  2015cites this paper
• Ethical Practice of Research Involving Humans

  2014cites this paper
• Attitude of epilepsy patients and their attendants for participating in research on status epilepticus

  2014cites this paper
• A Non-Paternalistic Model of Research Ethics and Oversight: Assessing the Benefits of Prospective Review

  2012cites this paper
• Ethics and eplerenone

  2012cites this paper
• The Commercialization of Genetic Research

  2012cites this paper
• Rethinking the Therapeutic Obligation in Clinical Research

  2012cites this paper
• Chapter 7 – TRIAL DESIGN, MEASUREMENT, AND ANALYSIS OF CLINICAL INVESTIGATIONS

  2011cites this paper
• THE ETHICS OF SHAM SURGERY IN PARKINSON'S DISEASE: BACK TO THE FUTURE?

  2011cites this paper
• A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations

  2011cites this paper
• When Ethics Constrains Clinical Research: Trial Design of Control Arms in “Greater Than Minimal Risk” Pediatric Trials

  2011cites this paper
• Placebo-controlled trials in pediatric urology: a cautionary view from an ethical perspective.

  2010cites this paper
• Evaluating equivalence and noninferiority trials.

  2010cites this paper
• A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders

  2009cites this paper
• Cancer Pain: Understanding clinical trials in pain research

  2009cites this paper
• The Rationale for Placebo-Controlled Trials: Methodology and Policy Considerations

  2009cites this paper
• The epistemic necessity and ethical permissibility of randomized clinical trials: A minimalist defense

  2008cites this paper
• Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.

  2008cites this paper
• Balancing ethical research and placebo administration

  2008cites this paper
• Chapter 72 – Ethical Considerations in Managing Critically Ill Patients

  2008cites this paper
• Bench to Bedside: Mapping the Moral Terrain of Clinical Research

  2008cites this paper
• International ethical regulations on placebo-use in clinical trials: a comparative analysis.

  2007cites this paper
• Clinical equipoise and the incoherence of research ethics.

  2007cites this paper
• applications in Parkinson's disease translation of stem cell research to clinical Benefits, risks and ethical considerations in

  2007cites this paper
• Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s disease

  2007cites this paper
• Placebo

  2007cites this paper
• Not all placebos are the same: a debate on the ethics of placebo use in clinical trials versus clinical practice

  2007cites this paper
• Subjective Evaluations of Research Participation by Persons With Mental Illness

  2007cites this paper
• Pulling the Plug on Clinical Equipoise: A Critique of Miller and Weijer

  2007cites this paper
• Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.

  2006cites this paper
• Moral reasoning as a model for health promotion.

  2006cites this paper
• Placebos in klinischen Versuchsreihen

  2006cites this paper
• Timing invitations to participate in clinical research: preliminary versus informed consent.

  2005cites this paper
• Interested in European research ?

  2005cites this paper
• The ethics of placebo-controlled trials: the case of asthma.

  2005cites this paper
• Laparoscopy and reported pain among patients with endometriosis.

  2005cites this paper
• CHAPTER 6 – DESIGN, MEASUREMENT, AND ANALYSIS OF CLINICAL INVESTIGATIONS

  2005cites this paper
• Informed consent and the use of placebo in poland: Ethical and legal aspects

  2004cites this paper
• L’éthique de la recherche et l’usage du placebo: un état de la question au Canada

  2004influential citation
• Placebo Controlled Trials: Restrictions, Not Prohibitions

  2004cites this paper
• Placebo in the investigation of psychotropic drugs, especially antidepressants

  2004cites this paper
• Ethics in Psychiatric Research: Study Design Issues

  2004cites this paper
• Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)

  2004cites this paper
• [Research ethics and the use of placebo: status of the debate in Canada].

  2004cites this paper
• Using empirical data to inform the ethical evaluation of placebo controlled trials

  2004cites this paper
• Are all monitoring boundaries equally ethical?

  2003cites this paper
• The Ethics of Placebo‐Controlled Trials

  2003influential citation
• Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis.

  2003cites this paper
• A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials.

  2003cites this paper
• Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.

  2003cites this paper
• Is the Use of Placebo Controls Ethically Permissible in Clinical Trials of Agents Intended to Reduce Fractures in Osteoporosis?

  2003cites this paper
• The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia.

  2003cites this paper
• Understanding clinical trials in pain research

  2003cites this paper
• Scientific and Ethical Issues in the Use of Placebo and Active Controls in Clinical Trials

  2003cites this paper
• I Need a Placebo like I Need a Hole in the Head

  2002cites this paper
• The ethics of placebo-controlled trials.

  2002cites this paper
• The ethics of placebo-controlled trials.

  2002cites this paper
• Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics

  2002cites this paper
• Human rights and HIV‐positive women

  2002cites this paper
• The ethics of placebo in clinical psychopharmacology: the urgent need for consistent regulation.

  2002cites this paper
• Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?

  2002cites this paper
• Therapeutic Beneficence and Placebo Controls

  2002cites this paper
• Unnecessary use of placebo controls: the case of asthma clinical trials.

  2002cites this paper
• The better-than-nothing idea: debating the use of placebo controls.

  2002cites this paper
• Ethics in the design and conduct of clinical trials.

  2002cites this paper
• What Makes Placebo-Controlled Trials Unethical?

  2002influential citation
• Surgical “Placebo” Controls

  2002cites this paper
• When Argument Fails

  2002cites this paper
• Ethical Considerations in the Design and Conduct of International Clinical Trials 2 Chapter Two

  2001cites this paper
• The Ethical Use of Placebo Controls in Clinical Research: The Declaration of Helsinki

  2001cites this paper
• The Ethics of Medical Research on Humans

  2001cites this paper
• Response to Striefel and Glaros

  2001cites this paper
• Pills, Politics, and Placebos

  2001cites this paper
• The Ethics of Drug Research in Children

  2001cites this paper
• The ethics of social risk reduction in the era of the biological brain.

  2001cites this paper
• Placebos, Placebo Effect, and the Response to the Healing Situation: The Evolution of a Concept

  2001cites this paper
• Research in critical care: the challenge created by ethical standards.

  2001cites this paper
• Placebo-controlled trials of new drugs: ethical considerations.

  2001cites this paper
• The ethics of placebo-controlled trials--a middle ground.

  2001cites this paper
• The Globalization of Health Law: The Case of Permissibility of Placebo-based Research

  2000cites this paper